タンパク質結合アッセイ市場：技術、製品・サービス、エンドユーザー別-2025-2030年の世界予測

タンパク質結合アッセイ市場は、2023年に4億1,142万米ドルと評価され、2024年には4億4,080万米ドルに達すると予測され、CAGR 8.39%で成長し、2030年には7億2,319万米ドルに達すると予測されています。

タンパク質結合アッセイは、タンパク質とリガンド（薬物、ホルモン、その他の生体分子を含む）の相互作用を研究するために使用される極めて重要な分析技術です。タンパク質結合アッセイの適用範囲は、創薬、薬物動態学、毒性学的研究において、薬物の有効性、分布、排泄を理解するために必要なものです。これらのアッセイは製薬、バイオテクノロジー、臨床研究分野で広く使用されています。最終用途としては、複雑な生物学的相互作用の解明や標的治療の設計を目指す学術研究機関、受託研究機関（CRO）、政府研究機関などに広がっています。

市場の洞察によると、個別化医療に対する需要の高まりと、ハイスループットスクリーニングや人工知能などの先端技術の統合が、タンパク質結合アッセイの成長を促進しています。さらに、慢性疾患の有病率の上昇と新規治療薬の必要性が重要な触媒として作用しています。最新のビジネスチャンスは、アッセイの効率と精度を大幅に向上させる自動化の領域や、多次元のタンパク質相互作用を解析できるより洗練されたアッセイの開発に生じています。

しかしながら、高い運用コスト、技術的な複雑さ、熟練した専門家の不足といった課題が市場の成長を妨げています。さらに、非特異的結合の可能性や、in vitroとin vivoの結果のばらつきなど、データの信頼性に影響を与えかねない限界もあります。

事業の成長を促進するための技術革新の分野としては、アッセイを小型化するためのマイクロ流体技術の強化、様々なアッセイ技術を統合する統一プラットフォームの開発、タンパク質-リガンド相互作用をより正確に予測するための機械学習アルゴリズムの導入などが挙げられます。競合情勢が激化する中、企業は学術機関との連携に注力し、スキルギャップを克服するためのトレーニングプログラムに投資することで差別化を図ることができます。これらの戦略は、データの精度を向上させるだけでなく、医薬品開発パイプラインへの統合を合理化し、新興国市場の需要に応えるものです。

市場力学：急速に進化するタンパク質結合アッセイ市場の主要市場インサイトを公開

タンパク質結合アッセイ市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができ、また、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 創薬および薬剤開発におけるタンパク質結合アッセイ採用の増加
  • 後期段階での薬剤失敗率の高さ
• 市場抑制要因
  • アッセイ設計の標準化に関する制約
• 市場機会
  • 製薬企業による投資の増加
  • 公的機関および民間機関による新薬発見のための研究開発費の増加
• 市場の課題
  • インシリコ予測技術のイントロダクション

ポーターのファイブフォースタンパク質結合アッセイ市場をナビゲートする戦略ツール

ポーターのファイブフォース」フレームワークは、市場情勢の競合情勢を把握するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：タンパク質結合アッセイ市場における外部からの影響の把握

外部マクロ環境要因は、タンパク質結合アッセイ市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析タンパク質結合アッセイ市場における競合情勢の把握

タンパク質結合アッセイ市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックスタンパク質結合アッセイ市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、タンパク質結合アッセイ市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によりベンダーを明確かつ的確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨タンパク質結合アッセイ市場における成功への道筋を描く

タンパク質結合アッセイ市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を検討することで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大の可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品上市、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 医薬品の発見と開発におけるタンパク質結合アッセイの採用の増加
    • 後期段階の薬剤の失敗率が高い
  • 抑制要因
    • アッセイ設計の標準化に関する制約
  • 機会
    • 製薬会社の投資増加
    • 公的機関と民間組織による新薬発見への研究開発の増加
  • 課題
    • インシリコ予測技術のイントロダクション
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 タンパク質結合アッセイ市場：技術別

• 平衡透析
• 表面プラズモン共鳴
• 超遠心分離
• 限外濾過

第7章 タンパク質結合アッセイ市場製品とサービス別

• 機器
• キットと試薬
• サービス

第8章 タンパク質結合アッセイ市場：エンドユーザー別

• 契約調査機関
• 製薬・バイオテクノロジー企業

第9章 南北アメリカのタンパク質結合アッセイ市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第10章 アジア太平洋地域のタンパク質結合アッセイ市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第11章 欧州・中東・アフリカのタンパク質結合アッセイ市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第12章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• 3B Pharmaceuticals GmbH
• Abcam plc
• Absorption Systems LLC
• Admecell, Inc.
• Biotium, Inc.
• Creative Biolabs, Inc.
• Danaher Corporation
• EpiGentek Group Inc.
• Eurofins Scientific
• Evotec SE
• Glycotope GmbH
• HTDialysis, LLC
• Merck KGaA
• MicroBiopharm Japan Co., Ltd.
• MicroConstants, Inc.
• Promega Corporation
• Thermo Fisher Scientific, Inc.

LIST OF FIGURES

• FIGURE 1. PROTEIN BINDING ASSAYS MARKET RESEARCH PROCESS
• FIGURE 2. PROTEIN BINDING ASSAYS MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL PROTEIN BINDING ASSAYS MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL PROTEIN BINDING ASSAYS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL PROTEIN BINDING ASSAYS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL PROTEIN BINDING ASSAYS MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL PROTEIN BINDING ASSAYS MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL PROTEIN BINDING ASSAYS MARKET SIZE, BY PRODUCT & SERVICES, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL PROTEIN BINDING ASSAYS MARKET SIZE, BY PRODUCT & SERVICES, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL PROTEIN BINDING ASSAYS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL PROTEIN BINDING ASSAYS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. AMERICAS PROTEIN BINDING ASSAYS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 13. AMERICAS PROTEIN BINDING ASSAYS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. UNITED STATES PROTEIN BINDING ASSAYS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 15. UNITED STATES PROTEIN BINDING ASSAYS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. ASIA-PACIFIC PROTEIN BINDING ASSAYS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. ASIA-PACIFIC PROTEIN BINDING ASSAYS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. EUROPE, MIDDLE EAST & AFRICA PROTEIN BINDING ASSAYS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. EUROPE, MIDDLE EAST & AFRICA PROTEIN BINDING ASSAYS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. PROTEIN BINDING ASSAYS MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 21. PROTEIN BINDING ASSAYS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. PROTEIN BINDING ASSAYS MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL PROTEIN BINDING ASSAYS MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL PROTEIN BINDING ASSAYS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL PROTEIN BINDING ASSAYS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. PROTEIN BINDING ASSAYS MARKET DYNAMICS
• TABLE 7. GLOBAL PROTEIN BINDING ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL PROTEIN BINDING ASSAYS MARKET SIZE, BY EQUILIBRIUM DIALYSIS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL PROTEIN BINDING ASSAYS MARKET SIZE, BY SURFACE PLASMON RESONANCE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL PROTEIN BINDING ASSAYS MARKET SIZE, BY ULTRACENTRIFUGATION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL PROTEIN BINDING ASSAYS MARKET SIZE, BY ULTRAFILTRATION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL PROTEIN BINDING ASSAYS MARKET SIZE, BY PRODUCT & SERVICES, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL PROTEIN BINDING ASSAYS MARKET SIZE, BY INSTRUMENT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL PROTEIN BINDING ASSAYS MARKET SIZE, BY KITS & REAGENTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL PROTEIN BINDING ASSAYS MARKET SIZE, BY SERVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL PROTEIN BINDING ASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL PROTEIN BINDING ASSAYS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL PROTEIN BINDING ASSAYS MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. AMERICAS PROTEIN BINDING ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 20. AMERICAS PROTEIN BINDING ASSAYS MARKET SIZE, BY PRODUCT & SERVICES, 2018-2030 (USD MILLION)
• TABLE 21. AMERICAS PROTEIN BINDING ASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 22. AMERICAS PROTEIN BINDING ASSAYS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 23. ARGENTINA PROTEIN BINDING ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 24. ARGENTINA PROTEIN BINDING ASSAYS MARKET SIZE, BY PRODUCT & SERVICES, 2018-2030 (USD MILLION)
• TABLE 25. ARGENTINA PROTEIN BINDING ASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 26. BRAZIL PROTEIN BINDING ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 27. BRAZIL PROTEIN BINDING ASSAYS MARKET SIZE, BY PRODUCT & SERVICES, 2018-2030 (USD MILLION)
• TABLE 28. BRAZIL PROTEIN BINDING ASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 29. CANADA PROTEIN BINDING ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 30. CANADA PROTEIN BINDING ASSAYS MARKET SIZE, BY PRODUCT & SERVICES, 2018-2030 (USD MILLION)
• TABLE 31. CANADA PROTEIN BINDING ASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 32. MEXICO PROTEIN BINDING ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 33. MEXICO PROTEIN BINDING ASSAYS MARKET SIZE, BY PRODUCT & SERVICES, 2018-2030 (USD MILLION)
• TABLE 34. MEXICO PROTEIN BINDING ASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 35. UNITED STATES PROTEIN BINDING ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 36. UNITED STATES PROTEIN BINDING ASSAYS MARKET SIZE, BY PRODUCT & SERVICES, 2018-2030 (USD MILLION)
• TABLE 37. UNITED STATES PROTEIN BINDING ASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 38. UNITED STATES PROTEIN BINDING ASSAYS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 39. ASIA-PACIFIC PROTEIN BINDING ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 40. ASIA-PACIFIC PROTEIN BINDING ASSAYS MARKET SIZE, BY PRODUCT & SERVICES, 2018-2030 (USD MILLION)
• TABLE 41. ASIA-PACIFIC PROTEIN BINDING ASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 42. ASIA-PACIFIC PROTEIN BINDING ASSAYS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 43. AUSTRALIA PROTEIN BINDING ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 44. AUSTRALIA PROTEIN BINDING ASSAYS MARKET SIZE, BY PRODUCT & SERVICES, 2018-2030 (USD MILLION)
• TABLE 45. AUSTRALIA PROTEIN BINDING ASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 46. CHINA PROTEIN BINDING ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 47. CHINA PROTEIN BINDING ASSAYS MARKET SIZE, BY PRODUCT & SERVICES, 2018-2030 (USD MILLION)
• TABLE 48. CHINA PROTEIN BINDING ASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 49. INDIA PROTEIN BINDING ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 50. INDIA PROTEIN BINDING ASSAYS MARKET SIZE, BY PRODUCT & SERVICES, 2018-2030 (USD MILLION)
• TABLE 51. INDIA PROTEIN BINDING ASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 52. INDONESIA PROTEIN BINDING ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 53. INDONESIA PROTEIN BINDING ASSAYS MARKET SIZE, BY PRODUCT & SERVICES, 2018-2030 (USD MILLION)
• TABLE 54. INDONESIA PROTEIN BINDING ASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 55. JAPAN PROTEIN BINDING ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 56. JAPAN PROTEIN BINDING ASSAYS MARKET SIZE, BY PRODUCT & SERVICES, 2018-2030 (USD MILLION)
• TABLE 57. JAPAN PROTEIN BINDING ASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 58. MALAYSIA PROTEIN BINDING ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 59. MALAYSIA PROTEIN BINDING ASSAYS MARKET SIZE, BY PRODUCT & SERVICES, 2018-2030 (USD MILLION)
• TABLE 60. MALAYSIA PROTEIN BINDING ASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 61. PHILIPPINES PROTEIN BINDING ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 62. PHILIPPINES PROTEIN BINDING ASSAYS MARKET SIZE, BY PRODUCT & SERVICES, 2018-2030 (USD MILLION)
• TABLE 63. PHILIPPINES PROTEIN BINDING ASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 64. SINGAPORE PROTEIN BINDING ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 65. SINGAPORE PROTEIN BINDING ASSAYS MARKET SIZE, BY PRODUCT & SERVICES, 2018-2030 (USD MILLION)
• TABLE 66. SINGAPORE PROTEIN BINDING ASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 67. SOUTH KOREA PROTEIN BINDING ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 68. SOUTH KOREA PROTEIN BINDING ASSAYS MARKET SIZE, BY PRODUCT & SERVICES, 2018-2030 (USD MILLION)
• TABLE 69. SOUTH KOREA PROTEIN BINDING ASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 70. TAIWAN PROTEIN BINDING ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 71. TAIWAN PROTEIN BINDING ASSAYS MARKET SIZE, BY PRODUCT & SERVICES, 2018-2030 (USD MILLION)
• TABLE 72. TAIWAN PROTEIN BINDING ASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 73. THAILAND PROTEIN BINDING ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 74. THAILAND PROTEIN BINDING ASSAYS MARKET SIZE, BY PRODUCT & SERVICES, 2018-2030 (USD MILLION)
• TABLE 75. THAILAND PROTEIN BINDING ASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 76. VIETNAM PROTEIN BINDING ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 77. VIETNAM PROTEIN BINDING ASSAYS MARKET SIZE, BY PRODUCT & SERVICES, 2018-2030 (USD MILLION)
• TABLE 78. VIETNAM PROTEIN BINDING ASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 79. EUROPE, MIDDLE EAST & AFRICA PROTEIN BINDING ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 80. EUROPE, MIDDLE EAST & AFRICA PROTEIN BINDING ASSAYS MARKET SIZE, BY PRODUCT & SERVICES, 2018-2030 (USD MILLION)
• TABLE 81. EUROPE, MIDDLE EAST & AFRICA PROTEIN BINDING ASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 82. EUROPE, MIDDLE EAST & AFRICA PROTEIN BINDING ASSAYS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 83. DENMARK PROTEIN BINDING ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 84. DENMARK PROTEIN BINDING ASSAYS MARKET SIZE, BY PRODUCT & SERVICES, 2018-2030 (USD MILLION)
• TABLE 85. DENMARK PROTEIN BINDING ASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 86. EGYPT PROTEIN BINDING ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 87. EGYPT PROTEIN BINDING ASSAYS MARKET SIZE, BY PRODUCT & SERVICES, 2018-2030 (USD MILLION)
• TABLE 88. EGYPT PROTEIN BINDING ASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 89. FINLAND PROTEIN BINDING ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 90. FINLAND PROTEIN BINDING ASSAYS MARKET SIZE, BY PRODUCT & SERVICES, 2018-2030 (USD MILLION)
• TABLE 91. FINLAND PROTEIN BINDING ASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 92. FRANCE PROTEIN BINDING ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 93. FRANCE PROTEIN BINDING ASSAYS MARKET SIZE, BY PRODUCT & SERVICES, 2018-2030 (USD MILLION)
• TABLE 94. FRANCE PROTEIN BINDING ASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 95. GERMANY PROTEIN BINDING ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 96. GERMANY PROTEIN BINDING ASSAYS MARKET SIZE, BY PRODUCT & SERVICES, 2018-2030 (USD MILLION)
• TABLE 97. GERMANY PROTEIN BINDING ASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 98. ISRAEL PROTEIN BINDING ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 99. ISRAEL PROTEIN BINDING ASSAYS MARKET SIZE, BY PRODUCT & SERVICES, 2018-2030 (USD MILLION)
• TABLE 100. ISRAEL PROTEIN BINDING ASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 101. ITALY PROTEIN BINDING ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 102. ITALY PROTEIN BINDING ASSAYS MARKET SIZE, BY PRODUCT & SERVICES, 2018-2030 (USD MILLION)
• TABLE 103. ITALY PROTEIN BINDING ASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 104. NETHERLANDS PROTEIN BINDING ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 105. NETHERLANDS PROTEIN BINDING ASSAYS MARKET SIZE, BY PRODUCT & SERVICES, 2018-2030 (USD MILLION)
• TABLE 106. NETHERLANDS PROTEIN BINDING ASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 107. NIGERIA PROTEIN BINDING ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 108. NIGERIA PROTEIN BINDING ASSAYS MARKET SIZE, BY PRODUCT & SERVICES, 2018-2030 (USD MILLION)
• TABLE 109. NIGERIA PROTEIN BINDING ASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 110. NORWAY PROTEIN BINDING ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 111. NORWAY PROTEIN BINDING ASSAYS MARKET SIZE, BY PRODUCT & SERVICES, 2018-2030 (USD MILLION)
• TABLE 112. NORWAY PROTEIN BINDING ASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 113. POLAND PROTEIN BINDING ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 114. POLAND PROTEIN BINDING ASSAYS MARKET SIZE, BY PRODUCT & SERVICES, 2018-2030 (USD MILLION)
• TABLE 115. POLAND PROTEIN BINDING ASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 116. QATAR PROTEIN BINDING ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 117. QATAR PROTEIN BINDING ASSAYS MARKET SIZE, BY PRODUCT & SERVICES, 2018-2030 (USD MILLION)
• TABLE 118. QATAR PROTEIN BINDING ASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 119. RUSSIA PROTEIN BINDING ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 120. RUSSIA PROTEIN BINDING ASSAYS MARKET SIZE, BY PRODUCT & SERVICES, 2018-2030 (USD MILLION)
• TABLE 121. RUSSIA PROTEIN BINDING ASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 122. SAUDI ARABIA PROTEIN BINDING ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 123. SAUDI ARABIA PROTEIN BINDING ASSAYS MARKET SIZE, BY PRODUCT & SERVICES, 2018-2030 (USD MILLION)
• TABLE 124. SAUDI ARABIA PROTEIN BINDING ASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 125. SOUTH AFRICA PROTEIN BINDING ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 126. SOUTH AFRICA PROTEIN BINDING ASSAYS MARKET SIZE, BY PRODUCT & SERVICES, 2018-2030 (USD MILLION)
• TABLE 127. SOUTH AFRICA PROTEIN BINDING ASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 128. SPAIN PROTEIN BINDING ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 129. SPAIN PROTEIN BINDING ASSAYS MARKET SIZE, BY PRODUCT & SERVICES, 2018-2030 (USD MILLION)
• TABLE 130. SPAIN PROTEIN BINDING ASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 131. SWEDEN PROTEIN BINDING ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 132. SWEDEN PROTEIN BINDING ASSAYS MARKET SIZE, BY PRODUCT & SERVICES, 2018-2030 (USD MILLION)
• TABLE 133. SWEDEN PROTEIN BINDING ASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 134. SWITZERLAND PROTEIN BINDING ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 135. SWITZERLAND PROTEIN BINDING ASSAYS MARKET SIZE, BY PRODUCT & SERVICES, 2018-2030 (USD MILLION)
• TABLE 136. SWITZERLAND PROTEIN BINDING ASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 137. TURKEY PROTEIN BINDING ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 138. TURKEY PROTEIN BINDING ASSAYS MARKET SIZE, BY PRODUCT & SERVICES, 2018-2030 (USD MILLION)
• TABLE 139. TURKEY PROTEIN BINDING ASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 140. UNITED ARAB EMIRATES PROTEIN BINDING ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 141. UNITED ARAB EMIRATES PROTEIN BINDING ASSAYS MARKET SIZE, BY PRODUCT & SERVICES, 2018-2030 (USD MILLION)
• TABLE 142. UNITED ARAB EMIRATES PROTEIN BINDING ASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 143. UNITED KINGDOM PROTEIN BINDING ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 144. UNITED KINGDOM PROTEIN BINDING ASSAYS MARKET SIZE, BY PRODUCT & SERVICES, 2018-2030 (USD MILLION)
• TABLE 145. UNITED KINGDOM PROTEIN BINDING ASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 146. PROTEIN BINDING ASSAYS MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 147. PROTEIN BINDING ASSAYS MARKET, FPNV POSITIONING MATRIX, 2023

The Protein Binding Assays Market was valued at USD 411.42 million in 2023, expected to reach USD 440.80 million in 2024, and is projected to grow at a CAGR of 8.39%, to USD 723.19 million by 2030.

Protein binding assays are pivotal analytical techniques used to study the interaction between proteins and ligands, which can include drugs, hormones, or other biomolecules. The scope of protein binding assays encompasses their necessity in drug discovery, pharmacokinetics, and toxicological studies to understand drug efficacy, distribution, and excretion. These assays are employed widely across pharmaceutical, biotechnology, and clinical research sectors. In terms of end-use, applications extend to academic research institutions, contract research organizations (CROs), and government research agencies seeking to unravel complex biological interactions and design targeted therapies.

Market insights reveal that the increasing demand for personalized medicine and the integration of advanced technologies, such as high-throughput screening and artificial intelligence, are driving the growth of protein binding assays. Additionally, the rising prevalence of chronic diseases and the need for novel therapeutics are acting as significant catalysts. The latest opportunities arise in the realm of automation, which can significantly enhance assay efficiency and accuracy, as well as in the development of more sophisticated assays capable of analyzing multi-dimensional protein interactions.

However, the market growth is hindered by challenges such as high operational costs, technical complexities, and a scarcity of skilled professionals. Furthermore, limitations include the potential for non-specific binding and the variability of in vitro versus in vivo results, which can affect data reliability.

To foster business growth, areas of innovation include the enhancement of microfluidic technologies for miniaturized assays, the development of unified platforms that integrate various assay technologies, and the implementation of machine learning algorithms to predict protein-ligand interactions more accurately. As the market landscape is increasingly competitive, companies can differentiate themselves by focusing on collaborations with academic institutions and investing in training programs to overcome skill gaps. These strategies not only improve data precision but also streamline integration into drug development pipelines, thus catering to evolving market demands.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Protein Binding Assays Market

The Protein Binding Assays Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Increase in adoption of protein binding assays in drug discovery & development
  • High rate of late stage drug failure
• Market Restraints
  • Constraints pertaining to standardization of assay designing
• Market Opportunities
  • Increasing investment by pharmaceutical companies
  • Rising research and development spends on novel drugs discovery by public and private organizations
• Market Challenges
  • Introduction of in-silico prediction techniques

Porter's Five Forces: A Strategic Tool for Navigating the Protein Binding Assays Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Protein Binding Assays Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Protein Binding Assays Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Protein Binding Assays Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Protein Binding Assays Market

A detailed market share analysis in the Protein Binding Assays Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Protein Binding Assays Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Protein Binding Assays Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Protein Binding Assays Market

A strategic analysis of the Protein Binding Assays Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Protein Binding Assays Market, highlighting leading vendors and their innovative profiles. These include 3B Pharmaceuticals GmbH, Abcam plc, Absorption Systems LLC, Admecell, Inc., Biotium, Inc., Creative Biolabs, Inc., Danaher Corporation, EpiGentek Group Inc., Eurofins Scientific, Evotec SE, Glycotope GmbH, HTDialysis, LLC, Merck KGaA, MicroBiopharm Japan Co., Ltd., MicroConstants, Inc., Promega Corporation, and Thermo Fisher Scientific, Inc..

Market Segmentation & Coverage

This research report categorizes the Protein Binding Assays Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Technology, market is studied across Equilibrium Dialysis, Surface Plasmon Resonance, Ultracentrifugation, and Ultrafiltration.
• Based on Product & Services, market is studied across Instrument, Kits & Reagents, and Services.
• Based on End-User, market is studied across Contract Research Organizations and Pharmaceutical & Biotechnology Companies.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increase in adoption of protein binding assays in drug discovery & development
    • 5.1.1.2. High rate of late stage drug failure
  • 5.1.2. Restraints
    • 5.1.2.1. Constraints pertaining to standardization of assay designing
  • 5.1.3. Opportunities
    • 5.1.3.1. Increasing investment by pharmaceutical companies
    • 5.1.3.2. Rising research and development spends on novel drugs discovery by public and private organizations
  • 5.1.4. Challenges
    • 5.1.4.1. Introduction of in-silico prediction techniques
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Protein Binding Assays Market, by Technology

• 6.1. Introduction
• 6.2. Equilibrium Dialysis
• 6.3. Surface Plasmon Resonance
• 6.4. Ultracentrifugation
• 6.5. Ultrafiltration

7. Protein Binding Assays Market, by Product & Services

• 7.1. Introduction
• 7.2. Instrument
• 7.3. Kits & Reagents
• 7.4. Services

8. Protein Binding Assays Market, by End-User

• 8.1. Introduction
• 8.2. Contract Research Organizations
• 8.3. Pharmaceutical & Biotechnology Companies

9. Americas Protein Binding Assays Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Protein Binding Assays Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Protein Binding Assays Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
• 12.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. 3B Pharmaceuticals GmbH
• 2. Abcam plc
• 3. Absorption Systems LLC
• 4. Admecell, Inc.
• 5. Biotium, Inc.
• 6. Creative Biolabs, Inc.
• 7. Danaher Corporation
• 8. EpiGentek Group Inc.
• 9. Eurofins Scientific
• 10. Evotec SE
• 11. Glycotope GmbH
• 12. HTDialysis, LLC
• 13. Merck KGaA
• 14. MicroBiopharm Japan Co., Ltd.
• 15. MicroConstants, Inc.
• 16. Promega Corporation
• 17. Thermo Fisher Scientific, Inc.